Skip to main content
Heartflow, Inc. logo

Heartflow, Inc. — Investor Relations & Filings

Ticker · HTFL US Human health and social work activities
Filings indexed 95 across all filing types
Latest filing 2026-04-29 Annual Report
Country US United States of America
Listing US HTFL

About Heartflow, Inc.

https://www.heartflow.com/

Heartflow, Inc. is a medical technology company focused on transforming the diagnosis and management of coronary artery disease (CAD). The company provides a non-invasive, AI-powered diagnostic solution that creates a personalized, dynamic 3D model of a patient's coronary arteries from a standard coronary CT angiogram (CCTA). Its core product, the Heartflow One platform, includes FFRCT Analysis to assess the physiological impact of blockages on blood flow, Plaque Analysis to quantify and characterize plaque, and Roadmap™ Analysis for efficient CCTA interpretation. This technology aims to improve diagnostic accuracy, reduce the need for unnecessary invasive procedures, and enable clinicians to develop personalized treatment plans for patients with suspected CAD.

Recent filings

Filing Released Lang Actions
ARS - Heartflow, Inc. (0001464521) (Filer)
Annual Report
2026-04-29 English
DEF 14A - Heartflow, Inc. (0001464521) (Filer)
Proxy Solicitation & Information Statement
2026-04-29 English
4 - Heartflow, Inc. (0001464521) (Issuer)
Director's Dealing
2026-03-26 English
4 - Heartflow, Inc. (0001464521) (Issuer)
Director's Dealing
2026-03-26 English
4 - Heartflow, Inc. (0001464521) (Issuer)
Director's Dealing
2026-03-23 English
4 - Heartflow, Inc. (0001464521) (Issuer)
Director's Dealing
2026-03-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.